Machine Learning-Enhanced Extraction of Biomarkers for High-Grade Serous Ovarian Cancer from Proteomics Data
Open Access
- 25 June 2024
- journal article
- research article
- Published by Springer Nature in Scientific Data
- Vol. 11 (1) , 1-11
Abstract
Comprehensive biomedical proteomic datasets are accumulating exponentially, warranting robust analytics to deconvolute them for identifying novel biological insights. Here, we report a strategic machine learning (ML)-based feature extraction workflow that was applied to unveil high-performing protein markers for high-grade serous ovarian carcinoma (HGSOC) from publicly available ovarian cancer tissue and serum proteomics datasets. Diagnosis of HGSOC, an aggressive form of ovarian cancer, currently relies on diagnostic methods based on tissue biopsy and/or non-specific biomarkers such as the cancer antigen 125 (CA125) and human epididymis protein 4 (HE4). Our newly developed ML-based approach enabled the identification of new serum proteomic biomarkers for HGSOC. The performance verification of these marker combinations using two independent cohorts affirmed their outperformance against known biomarkers for ovarian cancer including clinically used serum markers with >97% AUC. Our analysis also added novel biological insights such as enriched cancer-related processes associated with HGSOC.Keywords
This publication has 71 references indexed in Scilit:
- Basal cell adhesion molecule promotes metastasis‐associated processes in ovarian cancerClinical and Translational Medicine, 2023
- Long noncoding RNA HOTTIP promotes the metastatic potential of ovarian cancer through the regulation of the miR‐615‐3p/SMARCE1 pathwayThe Kaohsiung Journal of Medical Sciences, 2020
- Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinomaJournal of Cellular Physiology, 2019
- Efficient molecular subtype classification of high‐grade serous ovarian cancerThe Journal of Pathology, 2015
- Effect of Screening on Ovarian Cancer MortalityJAMA, 2011
- Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell line (SiHa)Journal of Cancer Research and Clinical Oncology, 2010
- Protease inhibitor SERPINA1 expression in epithelial ovarian cancerClinical & Experimental Metastasis, 2010
- Lumican, a small leucine‐rich proteoglycanIUBMB Life, 2008
- Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor‐specific fluorescent ligandsInternational Journal of Cancer, 2008
- Characterization of serum biomarkers for detection of early stage ovarian cancerProteomics, 2005